Naltrexone And Bupropion
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 68
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| NB medication | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- NB medication: endpoint not reported
- Placebo: endpoint not reported